After just uplisting to the TSX in Canada, Field Trip Health has applied to uplist to the NASDAQ in the U.S.
Exploring the companies and themes that make up this emerging and exciting new sector
Are Psychedelics The Ultimate Brain-Repair Drugs?
Psychedelic drugs increasingly appear to be powerful medicinal tools to rebuild broken brains.
Seattle City Council Promotes Psychedelics As Potential Tool Against Opioid Epidemic
Seattle lawmakers on Monday sent a letter to members of a local task force focused on the opioid overdose epidemic, imploring the group to investigate the therapeutic potential of psychedelics like ayahuasca and ibogaine in curbing addiction.
Increasing Interest in Psychedelics for Medical Purposes
Investors are always looking for hot new markets to invest in.
American Support For And Understanding Of Psychedelic Drugs Continues To Broaden
A Psychedelic Drug Revolution is underway to address the Mental Health Crisis. As with all revolutions, we are seeing a rapid shift in attitudes.
Feds Should Work With—Not Against—States That Legalize Psychedelics, Government Health Official Says
Oregon’s move to legalize psilocybin mushrooms for therapeutic use should signal to the federal government that it needs to engage with jurisdictions that pursue such reforms and aid in the development of regulatory frameworks, a federal health official says.
New York Bill Would Create State-Sponsored Psychedelics Research Institute
A New York lawmaker introduced a bill on Tuesday that would require the state to establish an institute to research the therapeutic potential of psychedelics.
California Senate Approves Bill To Legalize Possession Of Psychedelics Like Psilocybin And LSD
A bill to legalize possession of psychedelics in California was approved by the California Senate on Tuesday.
Psychedelic Drug Stocks: A BIG Healthcare Footprint At A SMALL Price
The psychedelic drug industry already has a large footprint in healthcare. And it is growing in literally every direction.
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights
Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.
Bill to Legalize Psilocybin Therapy Introduced in Maine
A bill filed in Maine would legalize psilocybin mushroom therapy without a medical diagnosis, and allow adults 21-and-older to legally buy the psychedelic and use it under the supervision of a certified psilocybin service practitioner, according to the Dales Report.
This is why psilocybin may be able to help millions
It may only be a matter of time before psychedelics become a go-to treatment for millions suffering with some sort of mental illness.